selected publications
-
conference paper
- Haemorheological changes during recombinante human erythropoietin therapy in a rat model of renal failure induced by partial nephrectomy 2008
- Higher fibrinolytic and inflammatory markers are associated with central venous catheters use in chronic kidney disease patients under haemodialysis 2008
- T-cell phenotype and inflammation in chronic kidney disease patients under haemodialysis and its relationship to resistance to rhEPO therapy 2008
- Altered erythrocyte membrane band 3 profile in chronic renal failure patients under haemodialysis 2007
- Band 3 as a marker of erythrocyte changes in chronic renal failure 2007
- Fibrinolytic activity and vascular access inchronic renal failure patients under haemodialysis 2007
- Fibrinolytic in chronic renal failure patients under haemodialysis and its retionship to recombinant human erythrpoietin resistance 2007
- Neuthrophil activation markers in chronic renal failure patients under haemodialysis and recombinant human erythropoietin 2007
-
journal article
- A Microfluidic Deformability Assessment of Pathological Red Blood Cells Flowing in a Hyperbolic Converging Microchannel. Micromachines. 645. 2019
- IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy. Blood Cells, Molecules and Diseases. 2008
- Inflammation, T-Cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. Journal of Clinical Immunology. 2008